EZRA — Reliance Global Group Inc.

Summary of Reliance Global Group Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Commission Income: $12.4 million for 2025, down from $14.1 million in 2024, primarily due to strategic divestitures.
• Net Loss: Improved to $7 million from $9.1 million in 2024, reflecting gains from asset sales and absence of prior year asset impairment charges.
• Adjusted EBITDA: Loss of $1.6 million, compared to a loss of $0.3 million in 2024, attributed to revenue fluctuations and increased operating costs.
• Balance Sheet Improvements:
  • Unrestricted cash rose 250% to $1.3 million.
  • Working capital increased 351% to $1.9 million.
  • Stockholders' equity grew 114% to $6.4 million.

2. Strategic Updates and Business Highlights

• Strategic Focus: Transitioning from traditional insurance to a technology-driven growth platform through two pillars: an InsurTech platform and the EZRA International Group.
• RELI Exchange Growth: Significant growth in personal lines, property, and casualty premiums (up 36% YoY) and a 72% increase in policies during health insurance open enrollment.
• Divestitures: Sold non-core operations (Fortman Insurance Services, Employee Benefits Solutions, U.S. Benefits Alliance) to streamline focus and redeploy capital toward high-growth opportunities.
• Investments: Initiated investments in Enquantum (post-quantum encryption technology) and Scentech Medical (AI diagnostic technology), aiming for majority ownership in both.

3. Forward Guidance and Outlook

• Scale51 Strategy: Management anticipates positive developments from the Scale51 strategy over the next 6-12 months, focusing on companies nearing revenue generation.
• Revenue Potential: Enquantum may begin generating revenue within the year, with significant market opportunities in cybersecurity due to the rise of quantum computing.
• Long-Term Vision: Reliance aims to evolve into a broader technology-focused entity while maintaining a stable insurance foundation.

4. Bad News, Challenges, or Points of Concern

• Declining Commission Income: The decrease in commission income due to divestitures raises concerns about immediate revenue generation capabilities.
• Increased Operating Costs: Higher salaries and general administrative expenses, partly due to noncash equity awards, may impact profitability.
• Market Risks: The transition to a technology-focused strategy involves inherent risks, including competition in the rapidly evolving tech landscape and the execution of new business models.

5. Notable Q&A Insights

• Scale51 Expectations: Management expressed optimism about the Scale51 strategy, emphasizing a focus on companies with established revenue potential rather than early-stage startups.
• Enquantum Development: The company is excited about Enquantum's progress and potential revenue generation within the year, highlighting the critical need for post-quantum encryption.
• Scentech's Unique Approach: The non-invasive breath analysis technology for disease detection, particularly for serious conditions like pancreatic cancer, was highlighted as a major differentiator, with potential life-saving implications.

Overall, Reliance Global Group is positioning itself for long-term growth through strategic divestitures and investments in technology, despite facing challenges related to declining commission income and increased operational costs.